In working toward the same goal, both medical professionals and benefits professionals face many of the same opportunities and challenges, particularly when it comes to the growing role of technology.

Mandatory arbitration agreements have found new scrutiny amid the #MeToo movement.

Generic drugs account for more than 90 percent of U.S. prescriptions. Overcapacity and the emergence of big purchasing groups have slammed manufacturers' margins.

Billy Bridwelll and Reid Rasmussen identify seven broad categories where brokers and their clients can focus their attention to make real differences in medical costs.